Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rapid Dose TherapeuticsRDTCF -7.61%29 Days Inventory is 40.48 as of Feb. 2026, which is 80% below its 10-year median of 201.49. GuruFocus rates RDTCF with a GF Score™ of 29/100 and a GF Value™ of $0.22 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 638 Biotechnology companies, Rapid Dose Therapeutics ranks better than 85.58% on this metric.
The historical rank and industry rank for Rapid Dose Therapeutics's Days Inventory or its related term are showing as below:
RDTCF'
s Days Inventory Range Over the Past 10 Years
Min: 52.68 Med: 201.49 Max: 1801.77
Current: 53.65
During the past 13 years, Rapid Dose Therapeutics's highest Days Inventory was 1801.77. The lowest was 52.68. And the median was 201.49.
RDTCF's Days Inventory is ranked better than 85.58% of 638
companies
in the Biotechnology industry
Industry Median: 183.195
vs RDTCF: 53.65
Rapid Dose Therapeutics's Days Inventory
declined
from Feb. 2025 (53.20) to Feb. 2026 (40.48).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Rapid Dose Therapeutics's Inventory Turnover for the
three
months ended in Feb. 2026 was 2.25.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Rapid Dose Therapeutics's Inventory-to-Revenue for the
three
months ended in Feb. 2026 was 0.25.
Rapid Dose Therapeutics (OTCPK:RDTCF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Rapid Dose Therapeutics's Inventory Turnover for the
three
months ended in Feb. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Rapid Dose Therapeutics's Inventory to Revenue for the
three
months ended in Feb. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Rapid Dose Therapeutics Days Inventory Related Terms
Rapid Dose Therapeutics Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RDTCF vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Rapid Dose Therapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rapid Dose Therapeutics Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Rapid Dose Therapeutics's Days Inventory distribution charts can be found below:
* The bar in red indicates where Rapid Dose Therapeutics's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rapid Dose Therapeutics (RDTCF) has a Days Inventory of 40.48 as of Feb. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Rapid Dose Therapeutics and its competitors. This is 80% below median its historical median of 201.49. Over the past decade, Rapid Dose Therapeutics' Days Inventory has ranged from 52.68 to 1,801.77. According to the industry distribution chart, Rapid Dose Therapeutics ranks #92 out of 638 companies in the Biotechnology industry, placing it in the top 14.4%.
Is Rapid Dose Therapeutics' Days Inventory too high?
Rapid Dose Therapeutics' current Days Inventory of 40.48 is 80% below median its 10-year median of 201.49. Over the past 10 years, this metric has ranged from a low of 52.68 to a high of 1,801.77. The Biotechnology industry median Days Inventory is 183.20. Rapid Dose Therapeutics' value of 40.48 is 77.9% below this industry median. Based on the distribution chart, Rapid Dose Therapeutics ranks #92 out of 638 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Rapid Dose Therapeutics has a GF Score™ of 29/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Rapid Dose Therapeutics' Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Rapid Dose Therapeutics ranks #92 out of 638 companies for Days Inventory. This places Rapid Dose Therapeutics in the top 14% of its industry — outperforming the majority of peers. The industry median Days Inventory is 183.20. Rapid Dose Therapeutics' value of 40.48 is 77.9% below this benchmark. Historically, Rapid Dose Therapeutics' own Days Inventory has ranged from 52.68 to 1,801.77 over the past decade. While the company's 10-year median is 201.49 vs. the industry median of 183.20, Rapid Dose Therapeutics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rapid Dose Therapeutics's current Days Inventory of 40.48 is 77.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Rapid Dose Therapeutics and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rapid Dose Therapeutics's current Days Inventory is 40.48, which is 80% below median its own 10-year median of 201.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rapid Dose Therapeutics stock overvalued right now?
Based on GuruFocus' analysis, Rapid Dose Therapeutics (RDTCF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.22, compared to a current price of $0.07 — trading 67% below its estimated fair value. The current Days Inventory is 40.48, which is 80% below median its 10-year median of 201.49 and 77.9% below the Biotechnology industry median of 183.20. Rapid Dose Therapeutics' overall GF Score™ is 29/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Rapid Dose Therapeutics (RDTCF), the current Days Inventory is 40.48 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rapid Dose Therapeutics (RDTCF) Overvalued in 2026?
Based on GuruFocus' analysis, Rapid Dose Therapeutics stock appears to be undervalued.
The current stock price of $0.07 is trading 67% below its estimated GF Value™ of $0.22.
GuruFocus considers Rapid Dose Therapeutics to be Possible Value Trap.
Key valuation signals for RDTCF:
Days Inventory: 40.48 (80% below median its 10-year median of 201.49)
GF Value™: $0.22 vs. price of $0.07 (67% below fair value)
Industry Position: 77.9% below the Biotechnology median (#92 of 638)
No single metric tells the full story. See the RDTCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, and cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.
29GF Score
Get the complete analysis for RDTCF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RDTCF has been successfully added to your 
